Regarding the anti-inflammatory cytokines, IL-1 receptor antagonists (IL-1Ra), IL-10, and IL-4 significantly increased across the different groups (mild, moderate, and severe) of COVID-19 patients. Here, IL10 is linked to COVID-19.